Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Mol Cancer Res. 2011 Nov 7;10(1):11–24. doi: 10.1158/1541-7786.MCR-11-0256

Table 1.

Concentration of CX3CL1 in samples of ovarian carcinoma and borderline gynecologic diseases determined by ELISA.

Sample CX3CL1
# Diagnosis ng/ml nM
1 Borderline endometrioid cystadenoma 2.50 0.29
2 Borderline mucinous cystadenoma 0.86 0.10
3 Serous cyst 1.25 0.15
4 Serous adenocarcinoma, Stage IV, Grade 3 20.00 2.30
5 Serous adenocarcinoma, Stage IV 25.00 3.00
6 Serous adenocarcinoma, Stage IIIc, Grade 3 25.00 3.00